Pediatric Clinical Immunology

Target population

Pediatric population.
Introduction

Primary immunodeficiency disorders (PID) are a group of rare diseases, hereditary in nature, i.e. with a genetic component, which affect the body’s immune system (especially blood cells and proteins). They may be either a quantitative or functional failure, or both.  There are more than 300 PIDs, described and classified according to the immune component that is failing. Some of these diseases are mild and others are severe, but they are considered chronic and orphan diseases. Late diagnosis, which in turn, delays timely treatment, leads to increased morbidity, compromised quality of life and increased mortality.

What is the target population?

The service is addressed to patients with recurrent infections, autoimmune diseases, severe allergies, with height and weight development compromised, where primary immunodeficiency is suspected.

You can have a consultation with a specialist in Pediatric Clinical Immunology, who may define, through basic or specialized paraclinical tests according to each case, the type of immunological alteration and the appropriate treatment for it. The service is supported by various departments: Pediatric Infectious Disease, Clinical Genetics, Pediatric Hemato-Oncology and Bone Marrow Transplantation, as well as palliative care assistance.

  1. Professionalism
  2. Experience
  3. Teamwork
  4. Capacity for performing diagnostic studies and, if needed, for referrals.
Specialist in Pediatric Clinical Immunology